Home > Back to Publisher > Report Information

Patent Foramen Ovale Closure Market: Clinical Trial Outcomes to Play a Key Role

GlobalData
October 12, 2009
15 Pages - SKU: GBDT2474927

Abstract Table of Contents Search inside this report Related Reports

Summary

Over the last decade there has been considerable evidence gathered, relating Patent Foramen Ovales (PFO) to migraines, cryptogenic stroke and decompression sickeness. There is an increased frequency of PFO in patients suffering from migraine- a frequency that almost parallels the presence of PFO in stroke. Currently, PFO closure is indicated for prevention of recurring stroke due to embolisms. A string of clinical trials are now underway to establish the relation between PFO to migraine especially. A positive outcome establishing this relation in any of these trials will lead to an increased acceptance of PFO closure in patients with migraine, as opposed to temporary relief from drugs. The medical device industry is also bracing itself in hope of clinical trials like the PREMIUM, with a strong pipeline of improved PFO closure devices slated for release in the next couple of years. Aided by this pipeline and possible positive outcomes from the trials, the PFO market could position itself as one with high investment opportunities.

Scope

Epidemiological data on the Patent Foramen Ovale (PFO) and its association with migrane
Data on market characteristics and clinical trials conducted in this sector
Review of key pipeline products related to PFO closure
Key drivers and restraints of the global PFO closure market

Reasons to buy

Design market entry and business strategies through insightful analysis of the global PFO closure market
Understand market dynamics within the global PFO closure market
Gain understanding of the key growth opportunities

Patent Foramen Ovale Closure Market: Clinical Trial Outcomes to Play a Key Role

Share this report

Other tasks

Research Assistance

Related Markets

CNS/Neurology Reports

Free Alert Me service